Circulation, Vol 90, 1319-1327, Copyright © 1994 by American Heart Association
WP Kopfler, M Willard, T Betz, JE Willard, RD Gerard and RS Meidell
BACKGROUND: In animal models of atherosclerosis, augmentation of
circulating high-density lipoprotein (HDL) cholesterol exerts a protective
effect against development of fatty streaks and promotes plaque regression.
METHODS AND RESULTS: To investigate the potential of gene transfer to
increase HDL cholesterol, a fusion gene encoding human apolipoprotein A-I
(apo A-I) under the control of the human cytomegalovirus (CMV)
immediate-early promoter was packaged into a recombinant adenovirus (AdCMV
apo A-I). BALB/c mice infected with AdCMV apo A-I by intravenous injection
accumulate immunoreactive apo A-I in serum; levels 5 days after infection
averaged 168 mg/dL. A 35% increase in HDL cholesterol and a 47% increase in
total cholesterol were observed in mice infected with AdCMV apo A-I
compared with control viruses. Analysis of size-fractionated lipoproteins
revealed that human apo A-I is incorporated into murine HDL particles.
Expression of human apo A-I declined to < 10% of maximum after 12 days
and mRNA encoding apo A-I, prevalent 5 days after infection, was
undetectable in the livers of infected mice after 12 days. CONCLUSIONS: We
conclude that adenovirus-mediated transfer of a gene encoding apo A-I
produces transient elevations of circulating HDL cholesterol of a magnitude
correlated with important physiological effects. These observations suggest
the potential for gene-based therapeutic strategies to reduce
cardiovascular risk.
ARTICLES
Adenovirus-mediated transfer of a gene encoding human apolipoprotein A- I into normal mice increases circulating high-density lipoprotein cholesterol
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8573.
This article has been cited by other articles:
![]() |
R. Renckens, J. J. T. H. Roelofs, S. Florquin, A. F. de Vos, J. M. Pater, H. R. Lijnen, P. Carmeliet, C. van 't Veer, and T. van der Poll Endogenous Tissue-Type Plasminogen Activator Is Protective during Escherichia coli-Induced Abdominal Sepsis in Mice J. Immunol., July 15, 2006; 177(2): 1189 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benjannet, D. Rhainds, R. Essalmani, J. Mayne, L. Wickham, W. Jin, M.-C. Asselin, J. Hamelin, M. Varret, D. Allard, et al. NARC-1/PCSK9 and Its Natural Mutants: ZYMOGEN CLEAVAGE AND EFFECTS ON THE LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL CHOLESTEROL J. Biol. Chem., November 19, 2004; 279(47): 48865 - 48875. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sinnaeve, J.-D. Chiche, H. Gillijns, N. Van Pelt, D. Wirthlin, F. Van de Werf, D. Collen, K. D. Bloch, and S. Janssens Overexpression of a Constitutively Active Protein Kinase G Mutant Reduces Neointima Formation and In-Stent Restenosis Circulation, June 18, 2002; 105(24): 2911 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sinnaeve, J.-D. Chiche, Z. Nong, O. Varenne, N. Van Pelt, H. Gillijns, D. Collen, K. D. Bloch, and S. Janssens Soluble Guanylate Cyclase {{alpha}}1 and {beta}1 Gene Transfer Increases NO Responsiveness and Reduces Neointima Formation After Balloon Injury in Rats via Antiproliferative and Antimigratory Effects Circ. Res., January 19, 2001; 88(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nagai, M. De Mol, H. R. Lijnen, P. Carmeliet, and D. Collen Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction : A Gene Targeting and Gene Transfer Study in Mice Circulation, May 11, 1999; 99(18): 2440 - 2444. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rabbani and E. J. Topol Strategies to achieve coronary arterial plaque stabilization Cardiovasc Res, February 1, 1999; 41(2): 402 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. M. van Vlijmen and J. Herz Gene Targets and Approaches for Raising HDL Circulation, January 12, 1999; 99(1): 12 - 14. [Full Text] [PDF] |
||||
![]() |
P. Benoit, F. Emmanuel, J. M. Caillaud, L. Bassinet, G. Castro, P. Gallix, J. C. Fruchart, D. Branellec, P. Denefle, and N. Duverger Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models Circulation, January 12, 1999; 99(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Spady, L. A. Woollett, R. S. Meidell, and H. H. Hobbs Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse J. Lipid Res., July 1, 1998; 39(7): 1483 - 1492. [Abstract] [Full Text] |
||||
![]() |
B. De Geest, Z. Zhao, D. Collen, and P. Holvoet Effects of Adenovirus-Mediated Human Apo A-I Gene Transfer on Neointima Formation After Endothelial Denudation in Apo E–Deficient Mice Circulation, December 16, 1997; 96(12): 4349 - 4356. [Abstract] [Full Text] |
||||
![]() |
B. Foger, S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer Jr. Plasma Phospholipid Transfer Protein. ADENOVIRUS-MEDIATED OVEREXPRESSION IN MICE LEADS TO DECREASED PLASMA HIGH DENSITY LIPOPROTEIN (HDL) AND ENHANCED HEPATIC UPTAKE OF PHOSPHOLIPIDS AND CHOLESTERYL ESTERS FROM HDL J. Biol. Chem., October 24, 1997; 272(43): 27393 - 27400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D Gerard and D. Collen Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis Cardiovasc Res, September 1, 1997; 35(3): 451 - 458. [Full Text] [PDF] |
||||
![]() |
P. Carmeliet, J.-M. Stassen, I. Van Vlaenderen, R. S. Meidell, D. Collen, and R. D. Gerard Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator-Deficient and Plasminogen Activator Inhibitor-1-Overexpressing Mice Blood, August 15, 1997; 90(4): 1527 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. Ehrengruber, C. A. Doupnik, Y. Xu, J. Garvey, M. C. Jasek, H. A. Lester, and N. Davidson Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons PNAS, June 24, 1997; 94(13): 7070 - 7075. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kobayashi, D. Applebaum-Bowden, K. A. Dugi, D. R. Brown, V. S. Kashyap, C. Parrott, C. Duarte, N. Maeda, and S. Santamarina-Fojo Analysis of Protein Structure-Function in Vivo. ADENOVIRUS-MEDIATED TRANSFER OF LIPASE LID MUTANTS IN HEPATIC LIPASE-DEFICIENT MICE J. Biol. Chem., October 18, 1996; 271(42): 26296 - 26301. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Nabel Gene Therapy for Cardiovascular Disease Circulation, January 15, 1995; 91(2): 541 - 548. [Full Text] |
||||
![]() |
K. Alam, R. S. Meidell, and D. K. Spady Effect of Up-regulating Individual Steps in the Reverse Cholesterol Transport Pathway on Reverse Cholesterol Transport in Normolipidemic Mice J. Biol. Chem., May 4, 2001; 276(19): 15641 - 15649. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |